Table 3: Analysis of clinical efficacy.
Apatinib |
||
Efficacy |
Number of patients (N=25) |
% |
Complete response |
0 |
0 |
Partial response |
3 |
12 |
Stable disease |
12 |
48 |
Disease progression |
10 |
40 |
Disease control rate (%) |
60 |
|
Overall response rate (%) |
12 |